Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

14.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.1K
Conserved Binding Sites01:49

Conserved Binding Sites

4.7K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.7K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

14.2K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.2K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.0K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.6K
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy.

Carbohydrate polymers·2020
Same author

β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors.

Cell·2020
Same author

Hypertension-Related Knowledge, Attitudes, and Behaviors among Community-Dwellers at Risk for High Blood Pressure in Shanghai, China.

International journal of environmental research and public health·2020
Same author

Morphology-dependent interfacial interactions of Fe<sub>2</sub>O<sub>3</sub> with Ag nanoparticles for determining the catalytic reduction of p-nitrophenol.

Journal of environmental sciences (China)·2020
Same author

siRNA and chemotherapeutic molecules entrapped into a redox-responsive platform for targeted synergistic combination therapy of glioma.

Nanomedicine : nanotechnology, biology, and medicine·2020
Same author

DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma.

PloS one·2020
Same journal

Modeling the impact of budget limitation on the screening and treatment pathway of HPV-induced precancerous cervical lesions.

Mathematical biosciences and engineering : MBE·2026
Same journal

Modeling the effects of trait-mediated dispersal on coexistence of two species: Competition and non-consumptive predator-prey.

Mathematical biosciences and engineering : MBE·2026
Same journal

A close look at the viral reduction rate in target cell limited models.

Mathematical biosciences and engineering : MBE·2026
Same journal

A stochastic agent-based model for simulating tumor-immune dynamics and evaluating therapeutic strategies.

Mathematical biosciences and engineering : MBE·2026
Same journal

Addressing domain shift via imbalance-aware domain adaptation in embryo development assessment.

Mathematical biosciences and engineering : MBE·2026
Same journal

Effect of drug resistance on an HIV epidemic in heterogeneous populations.

Mathematical biosciences and engineering : MBE·2026
See all related articles

Related Experiment Video

Updated: Oct 12, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.1K

Protein-ligand binding affinity prediction model based on graph attention network.

Hong Yuan1,2, Jing Huang1,2, Jin Li1,2

  • 1School of Medical Information and Engineering, Southwest Medical University, Luzhou, China.

Mathematical Biosciences and Engineering : MBE
|November 24, 2021
PubMed
Summary
This summary is machine-generated.

We developed GAT-Score, a graph attention network (GAT) model, to predict protein-ligand binding affinity. This novel approach improves upon traditional methods for structure-based drug design.

Keywords:
binding affinitygraph attention networkmachine learningscoring functionstructure-based drug design

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

69.1K

Related Experiment Videos

Last Updated: Oct 12, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.1K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

69.1K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Machine learning in drug discovery

Background:

  • Accurate estimation of protein-ligand binding affinity is crucial for structure-based drug design.
  • Machine learning models offer potential to enhance classical scoring functions for binding affinity prediction.

Purpose of the Study:

  • To develop a novel graph attention network (GAT) based model, GAT-Score, for predicting protein-ligand binding affinity.
  • To improve upon existing machine learning methods for binding affinity estimation in drug design.

Main Methods:

  • Representing protein-ligand complexes as graph structures where atoms are nodes.
  • Implementing a dynamic feature mechanism to incorporate bond information.
  • Introducing a virtual super node for aggregating node-level features into graph-level representations for regression tasks.
  • Training the model on the PDBbind database v.2018.

Main Results:

  • GAT-Score demonstrated superior performance compared to traditional machine learning models using molecular descriptors.
  • The model effectively handles graph-level regression problems for binding affinity prediction.
  • Validation using the $C_s$ (Core set) and Cross-Validation (CV) schemes confirmed the model's efficacy.

Conclusions:

  • The GAT-Score model offers a promising advancement in predicting protein-ligand binding affinity.
  • The proposed architectural improvements enhance the capability of graph attention networks for molecular modeling.
  • This method has significant implications for accelerating structure-based drug design and discovery.